BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 13, 2019
View Archived Issues
GSK-2702926A ameliorates a range of FXS-associated deficits in vivo
Read More
RNA circles the wagons in aggressive cancer
Read More
Simpler recipe for astrocyte-neuron conversion
Read More
Sangamo Therapeutics presents data from phase I/II EMPOWERS study of SB-318
Read More
FDA clears IND application for first-in-human study of PRGN-3005
Read More
M2SR shows protection against a highly mismatched influenza virus in phase II human challenge study
Read More
Preliminary data presented from a subgroup of patients in phase IIb study of NPS plus trastuzumab
Read More
Nitto BioPharma initiates phase I study of NBF-006
Read More
Enrollment ongoing in phase I study of CRV-101 vaccine candidate
Read More
Regimen delays neuroblastoma progression, prolongs survival
Read More
Pharmazz presents preliminary phase II data for PMZ-1620 in patients with cerebral ischemic stroke
Read More
Using ICAS to develop novel mouse model of moyamoya syndrome
Read More
Plasma BACE1 protein as a new biomarker for the diagnosis of cerebral amyloid angiopathy
Read More
Clinical and nonclinical data support entry of rodatristat into phase II this year
Read More
Targeting PKM improves outcome after ischemic stroke
Read More
New Bruton tyrosine kinase inhibitors discovered at Bristol-Myers Squibb
Read More
Isocure Biosciences patents mutant isocitrate dehydrogenase inhibitors
Read More
IFM Tre identifies new NLRP3 inflammasome inhibitors
Read More
Nanjing Sanhome Pharmaceutical synthsizes acetyl-CoA carboxylase inhibitors
Read More
Gyeonggido Business & Science Accelerator, Korpharm disclose benzylidene acetone derivatives
Read More
Jubilant enters drug discovery collaboration with Sanofi for neurological disorders
Read More
BioArctic's evaluation of SC-0806 for complete spinal cord injury progresses into phase II
Read More
ProMIS Neurosciences identifies MAbs targeting alpha-synuclein
Read More
Reproducible murine model of intracranial aneurysm developed
Read More
Zymeworks initiates phase I study of ZW-49 in HER2-positive cancers
Read More
Phase I interim data show mRNA-1653 boosts serum neutralization titers against hMPV and PIV3
Read More
Summit begins phase III trials of ridinilazole for C. difficile infection
Read More